Yusha Ikhtabar Siddiqui, MD
Internal Medicine · Redondo Beach
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
- Since medical school
- 20 years
- Graduated 2006
Offices
1 location · Torrance Health Association Inc · 298 clinicians in this group
Hospitals listed: Torrance Memorial Medical Center. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Siddiqui’s office at (310) 750-3300 to ask if they take your plan before you enroll.
California Medical Board record
Licence A121915 · Current
Licensed to practise in California · since 2012 · expires 2028-07-31 · Saint Petersburg State Medical Academy.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
School, training and certification
What this clinician told their state board, medical school and everything before it. Only some states publish this, so nothing here means the state does not say, not that there was no training or certification.
Specialty certification
- American Board of Internal Medicine - Internal Medicine
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Torrance Memorial Medical CenterTorrance, CAAcute Care Hospital · Voluntary non-profit - Other · Has an emergency department · Birthing-friendlyPart of Cedars Sinai Health System, which runs 4 hospitalsPatients rate it 3 of 5 · 82% would definitely recommend itOverall rating: 5 of 5 starsWorse than the national rate — CMS Medicare PSI 90: Patient safety and adverse events composite: 1.36 (1.11 to 1.61), Jul 2022 – Jun 2024Worse than the national rate — Postoperative respiratory failure rate: 15.79 (10.51 to 21.07) · 1,494 cases, Jul 2022 – Jun 2024Worse than the national rate — Pressure ulcer rate: 1.21 (0.72 to 1.71) · 9,154 cases, Jul 2022 – Jun 2024Better than the national rate — Clostridium Difficile (C.Diff): 0.328, Oct 2024 – Sep 2025
See every measure and the patient survey for Torrance Memorial Medical Center
Behind the star rating — Deaths: 3 better, 5 the same, 0 worse of 8 measures. Safety: 3 better, 4 the same, 1 worse of 8 measures. Readmissions: 0 better, 8 the same, 3 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.36 (1.11 to 1.61) | Worse | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 15.79 (10.51 to 21.07) · 1,494 cases | Worse | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 1.21 (0.72 to 1.71) · 9,154 cases | Worse | Jul 2022 – Jun 2024 |
| Clostridium Difficile (C.Diff)Infections | 0.328 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.85 (0 to 1.72) · 2,154 cases | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 171.72 (128.91 to 214.54) · 121 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.2 · 36 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 8 · 136 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.3 · 176 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 7.8 · 766 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 12.4 · 806 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.5 · 608 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.8 · 7,587 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.28 (0.1 to 0.47) · 11,109 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.21 (0.03 to 0.39) · 11,330 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 4.13 (2.41 to 5.85) · 2,964 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.64 (0.13 to 3.16) · 1,513 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.66 (1.3 to 4.01) · 2,802 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.24 (2.35 to 8.14) · 1,479 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.55 (0.11 to 2.98) · 650 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 2 · 962 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 1.023 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.646 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.751 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 1.259 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.658 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.1 · 300 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22.2 · 1,578 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 21.1 · 183 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 1.5 · 900 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 27.9 · 800 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 19.1 · 1,223 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.3 (3.3 to 8.3) · 26 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 10.5 (7 to 15) · 26 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.4 · 928 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 12 · 65 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 21 · 316 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.3 (9.5 to 16.1) · 624 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.7 to 1.2) · 781 cases | No different | Jan 2024 – Dec 2024 |
What patients said (2,607 patients answered, 26% of those asked)
| Cleanliness | 4 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 5 |
| Room was "always" clean | 74% |
| Nurses "always" communicated well | 78% |
| Doctors "always" communicated well | 78% |
| Staff "always" explained | 59% |
| Yes, staff "did" give patients this information | 87% |
| Yes, staff "did" give patients information about help after discharge | 83% |
| Doctors "always" explained things so they could understand | 73% |
| Doctors "always" listened carefully | 77% |
| Doctors "always" treated them with courtesy and respect | 84% |
| Patients who gave a rating of "9" or "10" (high) | 78% |
| Staff "always" explained new medications | 73% |
| Nurses "always" explained things so they could understand | 74% |
| Nurses "always" listened carefully | 76% |
| Nurses "always" treated them with courtesy and respect | 85% |
| "Always" quiet at night | 51% |
| "YES", patients would definitely recommend the hospital | 82% |
| Staff "always" explained possible side effects | 46% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$61,645
Medicare paid this office $61,645 for 244 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 213 | $40,585 | $100 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 44 | $6,161 | $140 |
| Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | 12 | $3,431 | $286 |
| New patient visit (45+ min) | 12 | $1,411 | $118 |
| Influenza vaccine split virus, preservative free | 16 | $1,351 | $79 |
See all 8 services
| Return visit (30+ min) | 213 | $40,585 | $100 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 44 | $6,161 | $140 |
| Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | 12 | $3,431 | $286 |
| New patient visit (45+ min) | 12 | $1,411 | $118 |
| Influenza vaccine split virus, preservative free | 16 | $1,351 | $79 |
| Administration of influenza virus vaccine | 17 | $630 | $35 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 43 | $546 | $12 |
| Administration of pneumococcal vaccine | 13 | $455 | $35 |
Who their Medicare patients are
244 Original Medicare patients in 2024. Average age 76 · Women 70% · Also on Medicaid 6% · Health risk score 1.30. At or below the middle of the specialty; the typical internal medicine clinician is at 1.76.
Conditions among them: High blood pressure 72% · Depression 27% · Chronic kidney disease 26% · Cancer 24% · Coronary heart disease 23% · Diabetes 22% · Atrial fibrillation 19% · Heart failure 16% · COPD 11% · Dementia 10% · Stroke 5%.
The office billed $119,512, Medicare allowed $79,514 and paid $61,645; for 675 services of 39 kinds; $4,947 of it was for drugs given in the office and $56,698 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 244 | 675 | 76 | 1.30 | $119,512 | $61,645 |
| 2023 | 307 | 692 | 77 | 1.09 | $117,430 | $64,307 |
| 2022 | 167 | 276 | 78 | 1.21 | $45,251 | $23,492 |
| 2021 | 157 | 338 | 78 | 1.05 | $53,657 | $32,507 |
| 2020 | 56 | 80 | 75 | 1.10 | $10,916 | $3,997 |
| 2019 | 148 | 293 | 77 | 1.22 | $37,812 | $22,535 |
| 2018 | 239 | 826 | 79 | 1.46 | $226,053 | $69,743 |
| 2017 | 274 | 834 | 80 | 2.06 | $284,060 | $76,093 |
| 2016 | 149 | 466 | 78 | 2.41 | $197,734 | $44,188 |
| 2014 | 17 | 34 | 78 | 3.65 | $8,234 | $2,302 |
| 2013 | 362 | 1,076 | 77 | 1.88 | $242,802 | $88,932 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 9 services
| Return visit (30+ min) | 268 | $42,355 | $96 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 68 | $9,544 | $140 |
| Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | 14 | $3,956 | $283 |
| Influenza vaccine split virus, preservative free | 18 | $1,295 | $72 |
| New patient visit (45+ min) | 11 | $1,001 | $91 |
| Administration of influenza virus vaccine | 19 | $635 | $33 |
| Administration of pneumococcal vaccine | 14 | $468 | $33 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 24 | $317 | $13 |
| X-ray of chest, 2 views | 12 | $311 | $26 |
2022: 2 services
| Return visit (30+ min) | 150 | $15,880 | $88 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 16 | $2,312 | $145 |
2021: 3 services
| Return visit (30+ min) | 145 | $25,844 | $110 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 16 | $2,346 | $147 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 17 | $225 | $13 |
2020: 1 service
| Return visit (30+ min) | 50 | $2,679 | $47 |
2019: 5 services
| Return visit (30+ min) | 121 | $14,850 | $91 |
| New patient visit (45+ min) | 27 | $3,499 | $130 |
| Short return visit (20+ min) | 16 | $1,055 | $62 |
| Influenza vaccine split virus, preservative free | 16 | $878 | $55 |
| Administration of influenza virus vaccine | 18 | $334 | $19 |
2018: 10 services
| Return visit (30+ min) | 177 | $35,347 | $92 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 50 | $7,019 | $140 |
| Short return visit (20+ min) | 65 | $5,358 | $58 |
| New patient visit (45+ min) | 31 | $4,443 | $143 |
| Influenza vaccine split virus, preservative free | 67 | $3,487 | $52 |
| Pneumococcal vaccine, 23-valent | 31 | $3,273 | $106 |
| Transitional care management services for problem of high complexity | 14 | $3,112 | $222 |
| Pneumococcal vaccine, 13-valent | 15 | $2,942 | $196 |
| Administration of influenza virus vaccine | 69 | $1,775 | $26 |
| Administration of pneumococcal vaccine | 44 | $1,132 | $26 |
2017: 11 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 103 | $21,220 | $93 |
| Return visit (30+ min) | 97 | $17,500 | $100 |
| Hospital discharge day management, more than 30 minutes | 77 | $7,855 | $98 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 40 | $7,568 | $180 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 40 | $5,506 | $65 |
| Influenza vaccine split virus, preservative free | 52 | $2,499 | $48 |
| Short return visit (20+ min) | 26 | $2,284 | $67 |
| New patient visit (45+ min) | 14 | $2,128 | $152 |
| Administration of influenza virus vaccine | 50 | $1,615 | $32 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 11 | $1,524 | $139 |
| Administration of pneumococcal vaccine | 13 | $420 | $32 |
2016: 5 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 90 | $19,351 | $93 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 41 | $7,571 | $180 |
| Hospital discharge day management, more than 30 minutes | 70 | $7,196 | $97 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 56 | $6,944 | $64 |
| Hospital observation care on day of discharge | 14 | $922 | $66 |
2013: 8 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 170 | $29,615 | $82 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 98 | $15,925 | $159 |
| Hospital discharge day management, more than 30 minutes | 178 | $15,863 | $84 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 152 | $15,455 | $57 |
| Initial hospital observation care per day, typically 70 minutes | 21 | $3,057 | $146 |
| Hospital observation care on day of discharge | 50 | $2,878 | $56 |
| Follow-up observation care per day, typically 35 minutes | 16 | $1,645 | $82 |
| Follow-up observation care per day, typically 25 minutes | 16 | $1,135 | $57 |
Medicaid work
$0 in 2018
Medicaid paid $0 for 42 billed services this clinician did in 2018, up to 16 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| New patient visit (45+ min) | 42 | $0 |
| 2018 | 42 | 1 | 16 | $0 |
Drugs they prescribed that Part D paid
$158,396
Pharmacies billed $158,396 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
1,317 generic and fewer than 11 brand-name prescriptions · $158,396 in drug cost · 63 antibiotic prescriptions to 53 people · 26 antipsychotic prescriptions to people over 65.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Xeljanz | 12 | $73,345 | $6,112 |
| Eliquis | 22 | $22,335 | $1,015 |
| Balsalazide Disodium | 14 | $3,260 | $233 |
| Valacyclovir | 34 | $2,057 | $61 |
| Dexlansoprazole Dr | 11 | $1,762 | $160 |
See all 45 drugs
| Xeljanz | 12 | $73,345 | $6,112 |
| Eliquis | 22 | $22,335 | $1,015 |
| Balsalazide Disodium | 14 | $3,260 | $233 |
| Valacyclovir | 34 | $2,057 | $61 |
| Dexlansoprazole Dr | 11 | $1,762 | $160 |
| Synthroid | 12 | $996 | $83 |
| Duloxetine | 27 | $785 | $29 |
| Losartan | 58 | $739 | $13 |
| Atorvastatin | 75 | $708 | $9 |
| Ezetimibe | 20 | $628 | $31 |
| Levothyroxine | 61 | $627 | $10 |
| Metformin Hcl Er | 25 | $621 | $25 |
| Celecoxib | 11 | $519 | $47 |
| Amlodipine Besylate | 63 | $454 | $7 |
| Fluoxetine | 35 | $443 | $13 |
| Famotidine | 19 | $369 | $19 |
| Mirtazapine | 14 | $327 | $23 |
| Lisinopril | 37 | $312 | $8 |
| Pravastatin | 16 | $236 | $15 |
| Rosuvastatin | 27 | $235 | $9 |
| Simvastatin | 35 | $227 | $6 |
| Gabapentin | 14 | $219 | $16 |
| Buspirone | 31 | $208 | $7 |
| Metoprolol | 22 | $200 | $9 |
| Atenolol | 14 | $195 | $14 |
| Hydralazine | 11 | $176 | $16 |
| Hydrochlorothiazide | 23 | $173 | $8 |
| Escitalopram | 12 | $170 | $14 |
| Nitrofurantoin Mono-Macro | 12 | $167 | $14 |
| Pantoprazole | 23 | $157 | $7 |
| Hydroxyzine | 11 | $154 | $14 |
| Omeprazole | 21 | $151 | $7 |
| Quetiapine | 26 | $136 | $5 |
| Tamsulosin | 16 | $135 | $8 |
| Montelukast | 18 | $132 | $7 |
| Sertraline | 17 | $127 | $7 |
| Valsartan-Hydrochlorothiazide | 13 | $114 | $9 |
| Carvedilol | 13 | $93 | $7 |
| Potassium Chloride | 11 | $82 | $7 |
| Fluticasone Propionate | 11 | $75 | $7 |
| Furosemide | 23 | $69 | $3 |
| Desvenlafaxine Succinate Er | 11 | $64 | $6 |
| Azithromycin | 11 | $52 | $5 |
| Trazodone | 12 | $40 | $3 |
| Temazepam | 13 | $33 | $3 |
Year by year
| 2024 | 1,473 | 289 | None | None | $158,396 |
| 2023 | 1,469 | 288 | 1% (11) | 10% | $128,185 |
| 2022 | 1,131 | 209 | None | None | $68,704 |
| 2021 | 730 | 166 | 2% (16) | None | $42,251 |
| 2020 | 329 | 76 | None | None | $9,816 |
| 2019 | 1,229 | 276 | 1% (14) | 14% | $89,206 |
| 2018 | 2,767 | 253 | 3% (70) | 18% | $214,698 |
| 2017 | 594 | 141 | 4% (23) | None | $34,070 |
| 2016 | 80 | 37 | None | 15% | $2,587 |
| 2015 | 127 | 53 | None | 28% | $3,872 |
| 2014 | 360 | 135 | 7% (25) | None | $15,693 |
| 2013 | 277 | 121 | 6% (16) | 18% | $22,280 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 46 drugs
| Eliquis | 12 | $14,425 | $1,202 |
| Ozempic | 13 | $12,533 | $964 |
| Xarelto | 11 | $7,526 | $684 |
| Atorvastatin | 103 | $1,313 | $13 |
| Valacyclovir | 26 | $1,274 | $49 |
| Losartan | 46 | $910 | $20 |
| Rosuvastatin | 23 | $798 | $35 |
| Levothyroxine | 67 | $775 | $12 |
| Famotidine | 37 | $648 | $18 |
| Albuterol Sulfate Hfa | 13 | $616 | $47 |
| Metformin Hcl Er | 26 | $507 | $19 |
| Pravastatin | 18 | $490 | $27 |
| Ezetimibe | 13 | $475 | $37 |
| Simvastatin | 46 | $464 | $10 |
| Tamsulosin | 23 | $443 | $19 |
| Metoprolol | 28 | $435 | $16 |
| Liothyronine | 11 | $424 | $39 |
| Hydralazine | 15 | $405 | $27 |
| Fluticasone Propionate | 33 | $398 | $12 |
| Esomeprazole Magnesium | 16 | $397 | $25 |
| Montelukast | 18 | $388 | $22 |
| Sertraline | 22 | $380 | $17 |
| Olmesartan Medoxomil | 13 | $368 | $28 |
| Amlodipine Besylate | 42 | $363 | $9 |
| Hydroxyzine | 14 | $355 | $25 |
| Lisinopril | 28 | $329 | $12 |
| Quetiapine | 20 | $320 | $16 |
| Bupropion Hcl Sr | 14 | $313 | $22 |
| Escitalopram | 18 | $279 | $16 |
| Omeprazole | 16 | $250 | $16 |
| Buspirone | 16 | $245 | $15 |
| Duloxetine | 15 | $232 | $15 |
| Mirtazapine | 14 | $200 | $14 |
| Potassium Chloride | 15 | $194 | $13 |
| Nitrofurantoin Mono-Macro | 11 | $189 | $17 |
| Alendronate | 12 | $187 | $16 |
| Hydrochlorothiazide | 27 | $181 | $7 |
| Paxlovid (Eua) | 17 | $174 | $10 |
| Furosemide | 28 | $139 | $5 |
| Trazodone | 14 | $116 | $8 |
| Metformin | 14 | $114 | $8 |
| Citalopram Hbr | 16 | $90 | $6 |
| Metoprolol | 11 | $78 | $7 |
| Azithromycin | 15 | $55 | $4 |
| Zolpidem | 12 | $52 | $4 |
| Ibuprofen | 12 | $27 | $2 |
2022: 29 drugs
| Eliquis | 14 | $12,430 | $888 |
| Januvia | 20 | $10,056 | $503 |
| Atorvastatin | 85 | $1,183 | $14 |
| Levothyroxine | 61 | $1,010 | $17 |
| Rosuvastatin | 17 | $861 | $51 |
| Hydralazine | 38 | $624 | $16 |
| Metoprolol | 31 | $526 | $17 |
| Fluticasone Propionate | 31 | $474 | $15 |
| Amlodipine Besylate | 42 | $452 | $11 |
| Valsartan-Hydrochlorothiazide | 13 | $434 | $33 |
| Simvastatin | 45 | $380 | $8 |
| Fenofibrate | 12 | $375 | $31 |
| Metformin Hcl Er | 21 | $349 | $17 |
| Nitrofurantoin Mono-Macro | 12 | $339 | $28 |
| Losartan | 21 | $299 | $14 |
| Bupropion Hcl Sr | 14 | $275 | $20 |
| Alendronate | 17 | $248 | $15 |
| Famotidine | 20 | $213 | $11 |
| Escitalopram | 16 | $199 | $12 |
| Gabapentin | 17 | $198 | $12 |
| Allopurinol | 18 | $182 | $10 |
| Lisinopril | 17 | $152 | $9 |
| Meloxicam | 16 | $123 | $8 |
| Metoprolol | 11 | $103 | $9 |
| Omeprazole | 11 | $90 | $8 |
| Metformin | 11 | $84 | $8 |
| Azithromycin | 12 | $62 | $5 |
| Hydrochlorothiazide | 11 | $60 | $5 |
| Citalopram Hbr | 20 | $60 | $3 |
2021: 15 drugs
| Levothyroxine | 32 | $543 | $17 |
| Metoprolol | 20 | $536 | $27 |
| Valsartan | 11 | $442 | $40 |
| Bupropion Xl | 15 | $428 | $29 |
| Losartan | 28 | $419 | $15 |
| Amlodipine Besylate | 27 | $342 | $13 |
| Metformin Hcl Er | 16 | $328 | $20 |
| Atorvastatin | 29 | $283 | $10 |
| Gabapentin | 21 | $278 | $13 |
| Hydralazine | 16 | $244 | $15 |
| Fluticasone Propionate | 19 | $149 | $8 |
| Simvastatin | 17 | $133 | $8 |
| Lisinopril | 16 | $123 | $8 |
| Meloxicam | 16 | $88 | $6 |
| Zolpidem | 14 | $28 | $2 |
2020: 7 drugs
| Memantine | 18 | $404 | $22 |
| Metoprolol | 16 | $399 | $25 |
| Losartan | 34 | $379 | $11 |
| Atorvastatin | 29 | $270 | $9 |
| Levothyroxine | 12 | $254 | $21 |
| Amlodipine Besylate | 39 | $209 | $5 |
| Fluticasone Propionate | 17 | $136 | $8 |
2019: 28 drugs
| Memantine | 38 | $3,420 | $90 |
| Atorvastatin | 109 | $1,742 | $16 |
| Levothyroxine | 46 | $1,053 | $23 |
| Metoprolol | 17 | $739 | $43 |
| Losartan | 68 | $738 | $11 |
| Escitalopram | 16 | $520 | $33 |
| Pantoprazole | 37 | $511 | $14 |
| Furosemide | 49 | $469 | $10 |
| Lisinopril | 54 | $468 | $9 |
| Finasteride | 14 | $450 | $32 |
| Amlodipine Besylate | 39 | $425 | $11 |
| Simvastatin | 21 | $390 | $19 |
| Sertraline | 30 | $384 | $13 |
| Metformin | 22 | $354 | $16 |
| Fluticasone Propionate | 25 | $354 | $14 |
| Tamsulosin | 11 | $252 | $23 |
| Omeprazole | 13 | $233 | $18 |
| Glimepiride | 11 | $216 | $20 |
| Gabapentin | 13 | $204 | $16 |
| Hydrochlorothiazide | 24 | $183 | $8 |
| Atenolol | 16 | $141 | $9 |
| Carvedilol | 12 | $130 | $11 |
| Metoprolol | 17 | $124 | $7 |
| Donepezil | 14 | $122 | $9 |
| Azithromycin | 12 | $75 | $6 |
| Trazodone | 12 | $59 | $5 |
| Fluoxetine | 12 | $56 | $5 |
| Tramadol | 11 | $35 | $3 |
2018: 58 drugs
| Januvia | 18 | $17,446 | $969 |
| Victoza 3-Pak | 11 | $12,648 | $1,150 |
| Myrbetriq | 28 | $12,579 | $449 |
| Eliquis | 11 | $7,792 | $708 |
| Memantine | 78 | $5,736 | $74 |
| Toujeo Solostar | 14 | $5,628 | $402 |
| Advair Diskus | 14 | $5,379 | $384 |
| Advair Hfa | 12 | $5,100 | $425 |
| Linzess | 12 | $4,803 | $400 |
| Travatan Z | 13 | $3,289 | $253 |
| Atorvastatin | 173 | $3,054 | $18 |
| Risedronate | 21 | $2,938 | $140 |
| Levothyroxine | 88 | $1,915 | $22 |
| Tamsulosin | 48 | $1,243 | $26 |
| Synthroid | 21 | $1,210 | $58 |
| Potassium Chloride | 37 | $1,176 | $32 |
| Amlodipine Besylate | 113 | $1,111 | $10 |
| Metoprolol | 36 | $1,090 | $30 |
| Pantoprazole | 65 | $957 | $15 |
| Losartan | 80 | $919 | $11 |
| Gabapentin | 57 | $873 | $15 |
| Furosemide | 106 | $869 | $8 |
| Omeprazole | 53 | $812 | $15 |
| Hydralazine | 44 | $811 | $18 |
| Oxybutynin Chloride Er | 14 | $804 | $57 |
| Lisinopril | 86 | $786 | $9 |
| Metformin | 69 | $786 | $11 |
| Finasteride | 31 | $781 | $25 |
| Sertraline | 66 | $770 | $12 |
| Fluticasone Propionate | 52 | $764 | $15 |
| Quetiapine | 30 | $691 | $23 |
| Mirtazapine | 14 | $609 | $43 |
| Simvastatin | 32 | $581 | $18 |
| Duloxetine | 17 | $518 | $30 |
| Propranolol | 13 | $513 | $39 |
| Isosorbide Mononitrate Er | 17 | $383 | $23 |
| Hydrochlorothiazide | 66 | $369 | $6 |
| Diltiazem 24hr Er (Cd) | 17 | $360 | $21 |
| Donepezil | 39 | $353 | $9 |
| Ciprofloxacin | 25 | $328 | $13 |
| Trazodone | 45 | $289 | $6 |
| Carvedilol | 31 | $254 | $8 |
| Glimepiride | 15 | $230 | $15 |
| Levetiracetam | 19 | $225 | $12 |
| Tramadol | 51 | $222 | $4 |
| Alendronate | 17 | $209 | $12 |
| Metoprolol | 25 | $206 | $8 |
| Hydrocodone-Acetaminophen | 12 | $200 | $17 |
| Glipizide | 23 | $197 | $9 |
| Pioglitazone | 13 | $196 | $15 |
| Atenolol | 23 | $174 | $8 |
| Buspirone | 14 | $163 | $12 |
| Hydroxyzine | 18 | $148 | $8 |
| Paroxetine | 15 | $132 | $9 |
| Zolpidem | 14 | $115 | $8 |
| Clonazepam | 11 | $104 | $9 |
| Citalopram Hbr | 14 | $100 | $7 |
| Lamotrigine | 12 | $59 | $5 |
2017: 16 drugs
| Myrbetriq | 16 | $6,016 | $376 |
| Memantine | 14 | $755 | $54 |
| Atorvastatin | 28 | $392 | $14 |
| Levothyroxine | 16 | $368 | $23 |
| Metoprolol | 11 | $314 | $29 |
| Furosemide | 38 | $225 | $6 |
| Pantoprazole | 12 | $187 | $16 |
| Potassium Chloride | 13 | $175 | $13 |
| Lisinopril | 18 | $172 | $10 |
| Amlodipine Besylate | 14 | $169 | $12 |
| Fluticasone Propionate | 11 | $153 | $14 |
| Gabapentin | 12 | $152 | $13 |
| Sertraline | 13 | $118 | $9 |
| Metoprolol | 14 | $89 | $6 |
| Azithromycin | 11 | $85 | $8 |
| Ciprofloxacin | 13 | $74 | $6 |
2015: 2 drugs
| Furosemide | 14 | $256 | $18 |
| Prednisone | 12 | $154 | $13 |
2014: 9 drugs
| Proair Hfa | 11 | $402 | $37 |
| Furosemide | 24 | $306 | $13 |
| Hydrocodone-Acetaminophen | 14 | $263 | $19 |
| Cefadroxil | 18 | $211 | $12 |
| Warfarin | 17 | $210 | $12 |
| Prednisone | 19 | $168 | $9 |
| Doxycycline Monohydrate | 13 | $156 | $12 |
| Metoprolol | 20 | $153 | $8 |
| Carvedilol | 13 | $85 | $7 |
2013: 4 drugs
| Levofloxacin | 16 | $123 | $8 |
| Prednisone | 20 | $75 | $4 |
| Metoprolol | 11 | $62 | $6 |
| Furosemide | 11 | $51 | $5 |
Money from drug and device companies
$458 in 2025
| 2025 | 8 | 21 | None | $458 |
| 2024 | 9 | 19 | None | $442 |
| 2023 | 7 | 8 | None | $175 |
| 2020 | 2 | 2 | None | $30 |
| 2019 | 6 | 10 | None | $213 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Pfizer | Prevnar 20 | $162 | 7 payments
|
| Abiomed | None | $86 | 3 payments
|
| GlaxoSmithKline | Shingrix | $65 | 3 payments
|
| Lilly USA | Mounjaro | $38 | 2 payments
|
| Kowa Pharmaceuticals America | Zoryve | $36 | 2 payments
|
| Novo Nordisk | Ozempic | $33 | 2 payments
|
See all 21 published payments
| Pfizer | Meals · 2025-12-10 | Eliquis | $22 |
| Pfizer | Meals · 2025-11-19 | Prevnar 20 | $29 |
| Kowa Pharmaceuticals America | Meals · 2025-10-22 | Zoryve | $19 |
| Otsuka America Pharmaceutical | Meals · 2025-10-15 | Jynarque | $24 |
| Exact Sciences | Meals · 2025-10-02 | The Cologuard Plus Collection Kit | $15 |
| Pfizer | Meals · 2025-10-01 | Prevnar 20 | $22 |
| Abiomed | Meals · 2025-09-03 | None | $37 |
| GlaxoSmithKline | Meals · 2025-08-20 | Shingrix | $21 |
| Kowa Pharmaceuticals America | Meals · 2025-07-02 | Zoryve | $17 |
| Pfizer | Meals · 2025-06-04 | Paxlovid | $24 |
| Abiomed | Meals · 2025-05-14 | None | $25 |
| Pfizer | Meals · 2025-04-23 | Prevnar 20 | $25 |
| Lilly USA | Meals · 2025-04-02 | Mounjaro | $16 |
| Novo Nordisk | Meals · 2025-04-02 | Ozempic | $16 |
| GlaxoSmithKline | Meals · 2025-03-19 | Shingrix | $19 |
| Abiomed | Meals · 2025-03-05 | None | $24 |
| Pfizer | Meals · 2025-02-26 | Paxlovid | $24 |
| GlaxoSmithKline | Meals · 2025-02-05 | Arexvy | $25 |
| Lilly USA | Meals · 2025-01-30 | Mounjaro | $22 |
| Pfizer | Meals · 2025-01-22 | Prevnar 20 | $17 |
| Novo Nordisk | Meals · 2025-01-14 | Ozempic | $17 |
See earlier years (2024, 2023, 2020, 2019)
2024: $442
| Amgen | Evenity | $94 | 4 payments
|
| Lilly USA | Mounjaro | $93 | 4 payments
|
| Pfizer | Prevnar 20 | $61 | 3 payments
|
| GlaxoSmithKline | Arexvy | $48 | 2 payments
|
| Novo Nordisk | Rybelsus | $45 | 2 payments
|
| Bayer Healthcare Pharmaceuticals | Kerendia | $26 | 1 payment
|
| Exact Sciences | Cologuard Collection Kit | $25 | 1 payment
|
| Boehringer Ingelheim Pharmaceuticals | Jardiance | $25 | 1 payment
|
| Merck Sharp & Dohme | Gardasil | $24 | 1 payment
|
2023: $175
| Bayer Healthcare Pharmaceuticals | Kerendia | $37 | 2 payments
|
| GlaxoSmithKline | Arexvy | $28 | 1 payment
|
| Amgen | Evenity | $25 | 1 payment
|
| Exact Sciences | Cologuard Collection Kit | $24 | 1 payment
|
| Lilly USA | Mounjaro | $24 | 1 payment
|
| AstraZeneca Pharmaceuticals LP | Farxiga | $23 | 1 payment
|
| Novo Nordisk | Ozempic | $14 | 1 payment
|
2020: $30
| GlaxoSmithKline | Shingrix | $16 | 1 payment
|
| AstraZeneca Pharmaceuticals LP | Farxiga | $14 | 1 payment
|
2019: $213
| GlaxoSmithKline | Shingrix | $67 | 3 payments
|
| Amgen | Evenity | $54 | 2 payments
|
| Pfizer | Prevnar - 13 | $32 | 2 payments
|
| Vertiflex | Superion Iss | $24 | 1 payment
|
| Janssen Pharmaceuticals | Xarelto | $20 | 1 payment
|
| AstraZeneca Pharmaceuticals LP | Farxiga | $17 | 1 payment
|
Professional record
- NPI
- 1265662340
- Licence
- CA A121915, MI L1596376California A121915: Current · expires 2028-07-31
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- Yes
- Taxonomy
- Internal medicine (207R00000X)
- Mailing address
- 2490 Hospital Dr, Suite 104, Mountain View, CA, 94040
- NPI first listed
- 2009-07-22
- NPI last updated
- 2016-11-18
This is when the NPI record was last certified, not a medical board exam.